アンチエイジング治療市場：治療タイプ、エンドユーザー、流通チャネル別-2025～2030年世界予測

アンチエイジング治療市場は、2023年に479億2,000万米ドルと評価され、2024年には503億米ドルに達すると予測され、CAGR 5.06％で成長し、2030年には677億3,000万米ドルに達すると予測されています。

調査手法には、シワ、小ジワ、シミといった目に見える老化現象の軽減や予防を目的とした様々な製品や手法が含まれます。これには、クリームや美容液などの局所治療、ボトックスやフィラーなどの侵襲的施術、レーザー治療やマイクロダーマブレーションなどの先端技術が含まれます。これらの治療の必要性は主に、社会的な基準や平均寿命の伸びによって、若々しい外見を求める声が高まっていることに起因しています。これらの治療の適用範囲は多様な層にわたるが、特に若々しさを保ちたい中高年を対象としています。主要最終用途セグメントには、皮膚科クリニック、ウェルネス・センター、DIYホームソリューションなどがあります。

市場の成長には、加齢に対する意識の高まりと先進的アンチエイジング技術の利用可能性が大きく影響しています。加えて、可処分所得の増加や若々しい外見を優先する文化的要因も、需要の拡大に大きく寄与しています。しかし、市場の拡大は、高額な治療費、潜在的な副作用、厳しい規制上の制約といった課題に直面しています。また、誇張された主張や非現実的な期待に伴う幻滅により、特定の治療法の有効性に対する懐疑的な見方も広がっています。

このような課題にもかかわらず、天然成分や低侵襲技術を利用した新規治療法の開発には機会があふれており、より安全でホリスティックな解決策を求める需要の高まりに応えています。人工知能や遺伝学を活用し、個人のニーズに合わせてアンチエイジングレジメンを調整するパーソナライズド治療の革新は、有望な可能性を示しています。アンチエイジング治療市場は、急速な技術進歩や、有効性だけでなく持続可能性や倫理的調達も約束される製品への消費者嗜好のシフトに後押しされ、ダイナミックな動きを見せています。企業や研究者は、消費者の懐疑心に対処するため、厳密な有効性研究と透明性のあるコミュニケーションに注力すべきであり、また、イノベーションと倫理的市場プラクティスのバランスを確保しつつ、より多くの消費者を取り込むための費用対効果の高いソリューションの開発に注力すべきです。

市場力学：急速に進化するアンチエイジング治療市場における重要な市場洞察の解明

アンチエイジング治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢者の増加と美容整形手術件数の増加
  • 製造過程における調査研究と臨床の動き
  • 消費者の美容意識の高まり
• 市場抑制要因
  • アンチエイジング製品の高コストと製品の副作用の可能性
• 市場機会
  • 人間の肌の弾力性と引き締めを強化する技術の進歩
  • 研究開発への高額投資
• 市場課題
  • 施術や治療に対する政府の厳しい規制

ポーターのファイブフォース：アンチエイジング治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アンチエイジング治療市場における外部からの影響の把握

外部マクロ環境要因は、アンチエイジング治療市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：アンチエイジング治療市場における競合情勢の把握

アンチエイジング治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：アンチエイジング治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アンチエイジング治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：アンチエイジング治療市場における成功への道筋を描く

アンチエイジング治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加と美容整形手術の増加
    • 生産プロセスにおける調査調査と臨床運動の出現
    • 消費者の美に対する意識の高まり
  • 抑制要因
    • アンチエイジング製品の高コストと製品の副作用の可能性
  • 機会
    • 人間の肌の弾力性とハリを高める技術の進歩
    • 研究開発への多額の投資
  • 課題
    • 手順と治療に関する厳格な政府規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 アンチエイジング治療市場：治療タイプ別

• イントロダクション
• 腹部整形
• ニキビ治療
• 色素沈着防止
• ストレッチ防止治療
• しわ治療
• ケミカルピーリング
• まぶたの手術
• ヘアリスタレーション
• 脂肪吸引サービス
• 硬化療法

第7章 アンチエイジング治療市場：エンドユーザー別

• イントロダクション
• 40歳以上
• 25歳以下
• 25～40歳

第8章 アンチエイジング治療市場：流通チャネル別

• イントロダクション
• 病院・クリニック
• 高級サロン＆スパ

第9章 南北アメリカのアンチエイジング治療市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のアンチエイジング治療市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアンチエイジング治療市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie, Inc.
• Alma Lasers GmBH
• Bausch Health Companies Inc
• Beiersdorf AG
• Carol Cole Company, Inc
• Clarins Group
• Estee Lauder Inc.
• Galderma SA
• L'Oreal SA
• Mary Kay Inc.
• Oriflame Cosmetics Global SA
• Pierre Fabre Dermo-Cosmetique Usa, Inc.
• Procter & Gamble Company
• Proderma Light
• Sinclair Pharma Group

LIST OF FIGURES

• FIGURE 1. ANTI-AGEING TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. ANTI-AGEING TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTI-AGEING TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANTI-AGEING TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ABDOMINOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ACNE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-PIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-STRETCH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-WRINKLE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CHEMICAL PEEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HAIR RESTORATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LIPOSUCTION SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY 40 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BELOW 25 YEARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BETWEEN 25 AND 40, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LUXURY SALONS & SPAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 153. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Anti-Ageing Treatment Market was valued at USD 47.92 billion in 2023, expected to reach USD 50.30 billion in 2024, and is projected to grow at a CAGR of 5.06%, to USD 67.73 billion by 2030.

The anti-ageing treatment market encompasses a variety of products and methodologies aimed at reducing or preventing the visible signs of ageing, such as wrinkles, fine lines, and age spots. This includes topical treatments like creams and serums, invasive procedures such as Botox and fillers, and advanced technologies like laser therapy and microdermabrasion. The necessity for these treatments primarily stems from the growing desire for youthful appearances, driven by societal standards and increased life expectancy. Application of these treatments spans across diverse demographics, but particularly targets middle-aged to older adults looking to maintain a youthful aesthetic. Key end-use sectors include dermatology clinics, wellness centers, and do-it-yourself home solutions.

Market growth is notably influenced by increasing awareness about ageing and the availability of advanced anti-ageing technologies. Additionally, rising disposable incomes and cultural factors that prioritize youthful looks significantly contribute to the growing demand. However, market expansion faces challenges from high treatment costs, potential side effects, and stringent regulatory constraints. There is also a growing skepticism about the efficacy of certain treatments due to exaggerated claims and disillusionment following unrealistic expectations.

Despite these challenges, opportunities abound in the development of novel treatments that utilize natural ingredients and minimally invasive technologies, catering to a growing demand for safer and more holistic solutions. Innovations in personalized treatments, leveraging artificial intelligence and genetics to tailor anti-ageing regimens to individual needs, show promising potential. The market for anti-ageing treatment is dynamic, driven by rapid technological advancements and shifts in consumer preferences towards products that promise not only efficacy but also sustainability and ethical sourcing. Businesses and researchers should focus on rigorous efficacy studies and transparent communication to address consumer skepticism, and on developing cost-effective solutions to capture a broader audience, ensuring a balance between innovation and ethical market practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Ageing Treatment Market

The Anti-Ageing Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing geriatric population coupled with rising number of cosmetic surgeries
  • Emergence of research studies and clinical movements in the production process
  • Growing awareness of beauty in consumers
• Market Restraints
  • High cost of anti-aging products and possibility of side effects of products
• Market Opportunities
  • Technological advancement in enhancement of human skin elasticity and tightness
  • High investment for research and development
• Market Challenges
  • Stringent government regulations for procedure and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Ageing Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Ageing Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Ageing Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Ageing Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Ageing Treatment Market

A detailed market share analysis in the Anti-Ageing Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Ageing Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Ageing Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anti-Ageing Treatment Market

A strategic analysis of the Anti-Ageing Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anti-Ageing Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers GmBH, Bausch Health Companies Inc, Beiersdorf AG, Carol Cole Company, Inc, Clarins Group, Estee Lauder Inc., Galderma SA, L'Oreal SA, Mary Kay Inc., Oriflame Cosmetics Global SA, Pierre Fabre Dermo-Cosmetique Usa, Inc., Procter & Gamble Company, Proderma Light, and Sinclair Pharma Group.

Market Segmentation & Coverage

This research report categorizes the Anti-Ageing Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment Type, market is studied across Abdominoplasty, Acne Treatment, Anti-Pigmentation, Anti-Stretch Treatment, Anti-Wrinkle Treatment, Chemical Peel, Eyelid Surgery, Hair Restoration, Liposuction Service, and Sclerotherapy.
• Based on End User, market is studied across 40 Years and above, Below 25 Years, and Between 25 and 40.
• Based on Distribution Channel, market is studied across Hospitals & Clinics and Luxury Salons & Spas.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population coupled with rising number of cosmetic surgeries
    • 5.1.1.2. Emergence of research studies and clinical movements in the production process
    • 5.1.1.3. Growing awareness of beauty in consumers
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of anti-aging products and possibility of side effects of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in enhancement of human skin elasticity and tightness
    • 5.1.3.2. High investment for research and development
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations for procedure and treatments
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anti-Ageing Treatment Market, by Treatment Type

• 6.1. Introduction
• 6.2. Abdominoplasty
• 6.3. Acne Treatment
• 6.4. Anti-Pigmentation
• 6.5. Anti-Stretch Treatment
• 6.6. Anti-Wrinkle Treatment
• 6.7. Chemical Peel
• 6.8. Eyelid Surgery
• 6.9. Hair Restoration
• 6.10. Liposuction Service
• 6.11. Sclerotherapy

7. Anti-Ageing Treatment Market, by End User

• 7.1. Introduction
• 7.2. 40 Years and above
• 7.3. Below 25 Years
• 7.4. Between 25 and 40

8. Anti-Ageing Treatment Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospitals & Clinics
• 8.3. Luxury Salons & Spas

9. Americas Anti-Ageing Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Anti-Ageing Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Anti-Ageing Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie, Inc.
• 2. Alma Lasers GmBH
• 3. Bausch Health Companies Inc
• 4. Beiersdorf AG
• 5. Carol Cole Company, Inc
• 6. Clarins Group
• 7. Estee Lauder Inc.
• 8. Galderma SA
• 9. L'Oreal SA
• 10. Mary Kay Inc.
• 11. Oriflame Cosmetics Global SA
• 12. Pierre Fabre Dermo-Cosmetique Usa, Inc.
• 13. Procter & Gamble Company
• 14. Proderma Light
• 15. Sinclair Pharma Group